Apoptosis in the human prostate

Drugs of Today

Volumn 37, Issue SUPPL. D, 2001, Pages 23-26

  Schalken, J A ^a  

^a Found Advancement of Urol Res   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANDROSTANOLONE; BASIC FIBROBLAST GROWTH FACTOR; DOXAZOSIN; EPIDERMAL GROWTH FACTOR; FINASTERIDE; KERATINOCYTE GROWTH FACTOR; PHENOXYBENZAMINE; STEROID 5ALPHA REDUCTASE; TAMSULOSIN; TERAZOSIN; TESTOSTERONE; TRANSFORMING GROWTH FACTOR;

APOPTOSIS; CELL PROLIFERATION; CONFERENCE PAPER; CYTOLOGY; DRUG EFFECT; HISTOLOGY; HUMAN; HUMAN CELL; MALE; PARACRINE SIGNALING; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY;

EID: 0034850015     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. 1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis
2. Induction of prostate apoptosis by doxazosin in benign prostatic hyperplasia
3. 1-Adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia
4. Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia
5. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia